<div>
	<table width="100%" border="0">
		<colgroup>
			<col width="20%">
			<col width="9%">
			<col width="7%">
			<col width="12%">
			<col width="8%">
			<col width="6%">
			<col width="10%">
			<col width="18%">
			<col width="10%">
		</colgroup>
		<tbody>
			<tr>
				<th><a title="Sort by Long Name"
					href="javascript:sort('Form(s)/Template(s)','Long Name');">
						Long Name </a></th>
				<th><a title="Sort by Public_ID"
					href="javascript:sort('Form(s)/Template(s)','Public_ID');">
						Public_ID </a></th>
				<th><a title="Sort by Version"
					href="javascript:sort('Form(s)/Template(s)','Version');">
						Version </a></th>
				<th><a title="Sort by Workflow Status"
					href="javascript:sort('Form(s)/Template(s)','Workflow Status');">
						Workflow Status </a></th>
				<th><a title="Sort by Context"
					href="javascript:sort('Form(s)/Template(s)','Context');">
						Context </a></th>
				<th><a title="Sort by Type"
					href="javascript:sort('Form(s)/Template(s)','Type');"> Type </a></th>
				<th><a title="Sort by Category"
					href="javascript:sort('Form(s)/Template(s)','Category');">
						Category </a></th>
				<th><a title="Sort by Protocol Long Name"
					href="javascript:sort('Form(s)/Template(s)','Protocol Long Name');">
						Protocol Long Name </a></th>
				<th><a title="Sort by Protocol ID"
					href="javascript:sort('Form(s)/Template(s)','Protocol ID');">
						Protocol ID </a></th>
			</tr>

			<tr class="rowColor">
				<td>/form-transfer-object/long-name</td>
				<td>3597295</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>TEST</td>
				<td>CRF</td>
				<td>Eligibility</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>2018 Revision 1 - Hodgkin and Non-Hodgkin Lymphoma Pre -
					HSCT Data</td>
				<td>3247335</td>
				<td>1.0</td>
				<td>RETIRED WITHDRAWN</td>
				<td>NHLBI</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>2018 Revision 1.1 - Hodgkin and Non-Hodgkin Lymphoma Pre -
					HSCT Data</td>
				<td>3434565</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>NHLBI</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>2018 Revision 1.1 - Hodgkin and Non-Hodgkin Lymphoma Pre -
					HSCT Data</td>
				<td>3247335</td>
				<td>1.1</td>
				<td>RETIRED WITHDRAWN</td>
				<td>NHLBI</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>2020 Revision 1.0 - Breast Cancer Pre-HSCT Data</td>
				<td>3467302</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>NHLBI</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>2022 Revision 1 - Testicular / Germ Cell Cancer Pre - HSCT
					Data</td>
				<td>3463080</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>NHLBI</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>2118 Revision 1 - Hodgkin and Non-Hodgkin Lymphoma
					Post-HSCT Data</td>
				<td>3250237</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>NHLBI</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Adult Soft Tissue Sarcoma - On-Study Form Newly Diagnosed
					Patients</td>
				<td>2281236</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Adult Soft Tissue Sarcoma - On-Study Form Recurrent
					Treatment</td>
				<td>2289393</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Advanced Bladder/Urothelial Cancer - Follow-Up Form</td>
				<td>2019343</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Advanced Melanoma-On-study Form</td>
				<td>2020195</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>AMC-045 Delayed Toxicity Form (TOX)</td>
				<td>2514820</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Toxicity</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>ANBL0321: Relapse/Progression Worksheet</td>
				<td>2089510</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>COG ANBL0321</td>
				<td>ANBL0321</td>
			</tr>

			<tr>
				<td>ANBL1221 On-Study</td>
				<td>3565246</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>ANBL1221: Relapse/Progression</td>
				<td>3574804</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Baseline Disease Evaluation Form (RECIST)</td>
				<td>2047526</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>E6201</td>
				<td>E6201</td>
			</tr>

			<tr class="rowColor">
				<td>BIG 2-06 / NCCTG N063D / EGF106708 - Month 24</td>
				<td>2651023</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>BIG 2-06 / NCCTG N063D / EGF106708 - Month 60</td>
				<td>2645643</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>BIG 2-06 / NCCTG N063D / EGF106708 - Months 36 and 48</td>
				<td>2645379</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>BIG 2-06 / NCCTG N063D / EGF106708 - Screening</td>
				<td>2646496</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>BIG 2-06 / NCCTG N063D / EGF106708 - Unscheduled
					Radiological Exams</td>
				<td>2644437</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>BIG 2-06 / NCCTG N063D / EGF106708 - Week 52</td>
				<td>2650896</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Bone Sarcoma - On-Study Form Newly Diagnosed Patients</td>
				<td>2291479</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Bone Sarcoma - On-Study Form Recurrent Treatment</td>
				<td>2290047</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Breast Cancer - Advanced Disease On-Study Form</td>
				<td>2262184</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Breast Cancer DataMart Common Data Elements for Adjuvant
					Clinical Trials</td>
				<td>2719861</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Breast Pathology Form</td>
				<td>2020193</td>
				<td>2.31</td>
				<td>RETIRED ARCHIVED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Pathology</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Breast Pathology Form</td>
				<td>2020193</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Pathology</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB 30506 Follow-Up Form</td>
				<td>2817823</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB 40503 BASELINE SOLID TUMOR EVALUATION FORM</td>
				<td>2550815</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB 40503 FOLLOW-UP SOLID TUMOR EVALUATION FORM</td>
				<td>2550906</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB 40503 ON-STUDY FORM</td>
				<td>2551476</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB 40601 FOLLOW-UP SOLID TUMOR EVALUATION FORM</td>
				<td>2690188</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB 50901 On-Study Form</td>
				<td>3211664</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB 80702 Follow-Up Form</td>
				<td>2969941</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB 90601: Follow-Up Form</td>
				<td>2854207</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB 90601: On-Study Form</td>
				<td>2848840</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB 90802 Follow-Up Form</td>
				<td>3103194</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB 90802 On-Study Form</td>
				<td>3107346</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB BASELINE SOLID TUMOR EVALUATION FORM</td>
				<td>2690488</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB-40502 On-Study Form</td>
				<td>2765928</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB: 140503 Follow-Up Form</td>
				<td>2538338</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB: 30607 Follow-Up and Response Form</td>
				<td>2664999</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB: 30607 Treatment and Response Form</td>
				<td>2664196</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB: 30610 Follow-Up and Response Form</td>
				<td>2688976</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB: 30610 Treatment and Response Form</td>
				<td>2688627</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>CALGB: 30801 Follow-Up and Response Form</td>
				<td>2891478</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB: 49903 Advanced Disease On-study Form</td>
				<td>2054656</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>CALGB 49903</td>
				<td>CALGB 49903</td>
			</tr>

			<tr class="rowColor">
				<td>CALGB: 80101 Follow-up/Relapse Form</td>
				<td>2037302</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>CALGB80101</td>
				<td>CALGB80101</td>
			</tr>

			<tr>
				<td>CALGB: 80405 FOLLOW-UP AND RESPONSE FORM</td>
				<td>2307981</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>C80405</td>
				<td>C80405</td>
			</tr>

			<tr class="rowColor">
				<td>CALGB: 80405 ON-STUDY FORM</td>
				<td>2308078</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>C80405</td>
				<td>C80405</td>
			</tr>

			<tr>
				<td>CALGB: 80405 TREATMENT AND RESPONSE FORM</td>
				<td>2308422</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td>C80405</td>
				<td>C80405</td>
			</tr>

			<tr class="rowColor">
				<td>CALGB: 80802 Follow-Up and Response Form</td>
				<td>2943577</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CALGB: 90104 Treatment and Follow-up Form</td>
				<td>2169531</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td>CALGB90104</td>
				<td>CALGB90104</td>
			</tr>

			<tr class="rowColor">
				<td>CALGB: 90401 FOLLOW-UP FORM</td>
				<td>2303005</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td>CALGB 90401</td>
				<td>CALGB 90401</td>
			</tr>

			<tr>
				<td>CALGB: 90401 ON-STUDY FORM</td>
				<td>2291160</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td>CALGB 90401</td>
				<td>CALGB 90401</td>
			</tr>

			<tr class="rowColor">
				<td>CALGB_40301_ON_STUDY_FORM</td>
				<td>2294326</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>CALGB-40301</td>
				<td>CALGB-40301</td>
			</tr>

			<tr>
				<td>CALGB_40302_ONSTUDY_FRM</td>
				<td>2221118</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>CALGB 40302</td>
				<td>CALGB 40302</td>
			</tr>

			<tr class="rowColor">
				<td>caTissue TCGA Lung CQCF</td>
				<td>3473096</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>TEST</td>
				<td>CRF</td>
				<td>Pathology</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>CHRONIC TRANSPLANT GRAFT VS. HOST DISEASE FORM</td>
				<td>2663289</td>
				<td>1.0</td>
				<td>RETIRED WITHDRAWN</td>
				<td>NHLBI</td>
				<td>TEMPLATE</td>
				<td>Toxicity</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Death Summary</td>
				<td>3422997</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>caBIG</td>
				<td>CRF</td>
				<td>Off Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Denise Test CRF</td>
				<td>3421713</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>TEST</td>
				<td>CRF</td>
				<td>Eligibility</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Diagnostic Procedure</td>
				<td>3588607</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Disease Assessment</td>
				<td>3390754</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Disease Assessment Test</td>
				<td>3396824</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>TEST</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Disease recurrence</td>
				<td>2498795</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>E1105 Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2496694</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>E1105 Nontarget Lesions Supplemental Form (RECIST)</td>
				<td>2490979</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>E1208 Baseline Disease Evaluation Form (RECIST)</td>
				<td>2923987</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>E1208 Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2925531</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>E1208 Nontarget Lesions Supplemental Form (RECIST)</td>
				<td>2924175</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>E1305 Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2501996</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>E1305 Nontarget Lesions Supplemental Form (RECIST)</td>
				<td>2501112</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>E1805 Follow-Up Disease Evaluation Form</td>
				<td>2462752</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>E1805</td>
				<td>E1805</td>
			</tr>

			<tr class="rowColor">
				<td>E1A06 Adverse Event Form (CTCAE v3)</td>
				<td>2705272</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Toxicity</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>E2108 Baseline Disease Evaluation Form (RECIST 1.1)</td>
				<td>3129560</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>E2108 Step 2 Disease Evaluation Form (RECIST 1.1)</td>
				<td>3129784</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>E2603 Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2298684</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>E2603</td>
				<td>E2603</td>
			</tr>

			<tr class="rowColor">
				<td>E2603 Nontarget Lesions Supplemental Form (RECIST) Form No.
					2170</td>
				<td>2298288</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>E2603</td>
				<td>E2603</td>
			</tr>

			<tr>
				<td>E5103 Adverse Event Form (CTCAE v3)</td>
				<td>2544497</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Toxicity</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>E5508 Baseline Disease Evaluation Form (RECIST 1.1)</td>
				<td>2907866</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>E5508 Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2905360</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>E5508 Nontarget Lesions Supplemental Form (RECIST)</td>
				<td>2908069</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>ECOG Baseline Disease Evaluation Form (RECIST)</td>
				<td>2490334</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>ECOG Baseline Disease Evaluation Form (RECIST)</td>
				<td>2500959</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>ECOG Baseline Disease Evaluation Form (RECIST)</td>
				<td>2233887</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>E3805</td>
				<td>E3805</td>
			</tr>

			<tr class="rowColor">
				<td>ECOG Baseline Disease Evaluation Form (RECIST)</td>
				<td>2297929</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>E2603</td>
				<td>E2603</td>
			</tr>

			<tr>
				<td>ECOG Baseline Disease Evaluation Form (RECIST)</td>
				<td>2045250</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>E4201</td>
				<td>E4201</td>
			</tr>

			<tr class="rowColor">
				<td>ECOG Baseline Disease Evaluation Form (RECIST), E2100</td>
				<td>2068306</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>E2100</td>
				<td>E2100</td>
			</tr>

			<tr>
				<td>ECOG Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2236344</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>E3805</td>
				<td>E3805</td>
			</tr>

			<tr class="rowColor">
				<td>ECOG Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2046702</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>E4201</td>
				<td>E4201</td>
			</tr>

			<tr>
				<td>ECOG Follow-Up Disease Evaluation Form (RECIST), E2100</td>
				<td>2067696</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>E2100</td>
				<td>E2100</td>
			</tr>

			<tr class="rowColor">
				<td>ECOG Nontarget Lesions Supplemental Form (E2100)</td>
				<td>2069328</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>E2100</td>
				<td>E2100</td>
			</tr>

			<tr>
				<td>Enrollment</td>
				<td>3276705</td>
				<td>3.0</td>
				<td>DRAFT NEW</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Registration</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Enrollment</td>
				<td>3276705</td>
				<td>1.0</td>
				<td>RETIRED PHASED OUT</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Registration</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Enrollment</td>
				<td>3276705</td>
				<td>2.0</td>
				<td>RELEASED</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Registration</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Esophageal Cancer - Adjuvant On-Study Form</td>
				<td>2020201</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Esophageal Cancer - Advanced On-Study Form</td>
				<td>2020202</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>EXTENT OF DISEASE</td>
				<td>2411517</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>caBIG</td>
				<td>CRF</td>
				<td>Response</td>
				<td>C3D Adopter Template Forms</td>
				<td></td>
			</tr>

			<tr>
				<td>Extent of Disease</td>
				<td>3372042</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Extent of Disease Identification</td>
				<td>3277353</td>
				<td>2.0</td>
				<td>RELEASED</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Extent of Disease Identification</td>
				<td>3277353</td>
				<td>1.0</td>
				<td>RETIRED PHASED OUT</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Extent of Disease Identification</td>
				<td>3277353</td>
				<td>3.0</td>
				<td>DRAFT NEW</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Follow-Up Disease Evaluation Form (RECIST)</td>
				<td>2050503</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>E6201</td>
				<td>E6201</td>
			</tr>

			<tr class="rowColor">
				<td>FORM 1 - ELIGIBILITY CHECK LIST AND INITIAL EVALUATION
					MA.27</td>
				<td>2067101</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>NCIC MA.27</td>
				<td>NCIC MA.27</td>
			</tr>

			<tr>
				<td>Form 1 - Eligibility Checklist and Initial Evaluation</td>
				<td>2055363</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>NCIC BR.19</td>
				<td>NCIC BR.19</td>
			</tr>

			<tr class="rowColor">
				<td>Gastric Cancer - Adjuvant On-Study Form</td>
				<td>2020203</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Gastric Cancer - Advanced On-Study Form</td>
				<td>2020204</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>GOG Recurrent Gynecologic Cancer - On Study Form</td>
				<td>2058732</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>GOG-0204</td>
				<td>GOG-0204</td>
			</tr>

			<tr>
				<td>GOG-0241 Recurrent Gynecologic Cancer - On Study Form (OSR)</td>
				<td>3127560</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>GOG-0263: Primary Cervical Cancer - On Study Form</td>
				<td>2933511</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Gynecologic Cancer - Follow-Up Form</td>
				<td>2019334</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Gynecologic Cancer - Follow-Up Form</td>
				<td>2019334</td>
				<td>2.31</td>
				<td>RETIRED ARCHIVED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Gynecologic Oncology Group Primary Cervical Cancer On Study
					Form (Form OSC)</td>
				<td>3563973</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Gynecologic Oncology Group Recurrent Gynecologic Cancer -
					On Study Form (Form OSR)</td>
				<td>2728090</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>GYNECOLOGIC ONCOLOGY GROUP Recurrent Gynecologic Cancer -
					On Study Form - FORM OSR</td>
				<td>2280475</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td>GOG-0213</td>
				<td>GOG-0213</td>
			</tr>

			<tr class="rowColor">
				<td>Head and Neck Cancers - Follow Up Form</td>
				<td>2268620</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Hodgkins Lymphoma - Baseline Disease Assessment Form</td>
				<td>2271087</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Hodgkins Lymphoma - Follow Up Form</td>
				<td>2269788</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Infection Episode</td>
				<td>3277947</td>
				<td>2.0</td>
				<td>RELEASED</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Infection Episode</td>
				<td>3347241</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Infection Episode</td>
				<td>3277947</td>
				<td>1.0</td>
				<td>RETIRED PHASED OUT</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Lung Cancer - NSCLC Advanced On-Study Form</td>
				<td>2263427</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Lung Cancer - NSCLC Second Line On-Study Form</td>
				<td>2286443</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Lymphoma Relapse Form</td>
				<td>2631004</td>
				<td>1.0</td>
				<td>RETIRED WITHDRAWN</td>
				<td>NHLBI</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Melanoma-Follow-up Form</td>
				<td>2020198</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Melanoma-Treatment By Cycle Form</td>
				<td>2020199</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Melanoma-Treatment Summary Form</td>
				<td>2020200</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Metastatic Bladder/Urothelial Cancer - On-Study Form</td>
				<td>2019330</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Metastatic Brain Cancer - On-Study Form</td>
				<td>2287553</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Multiple Myeloma - Follow Up Form</td>
				<td>2272994</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>NCI Cooperative Group Follow-Up Form (CALGB-90104)</td>
				<td>2056490</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>CALGB90104</td>
				<td>CALGB90104</td>
			</tr>

			<tr class="rowColor">
				<td>NCIC MA.32 Relapse/Progression Report Form</td>
				<td>3019298</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Nodal Site Assessment</td>
				<td>3338707</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Non-Hodgkins Lymphoma - Baseline Disease Assessment Form</td>
				<td>2270115</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Non-Hodgkins Lymphoma - Follow Up Form</td>
				<td>2270441</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Nontarget Lesions Supplemental Form</td>
				<td>2047073</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>E4201</td>
				<td>E4201</td>
			</tr>

			<tr>
				<td>Nontarget Lesions Supplemental Form</td>
				<td>2048270</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Response</td>
				<td>E6201</td>
				<td>E6201</td>
			</tr>

			<tr class="rowColor">
				<td>North Central Cancer Treatment Group N0723 On-Study Form</td>
				<td>2731649</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>North Central Cancer Treatment Group N0949 Event Monitoring
					Form</td>
				<td>3166854</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>North Central Cancer Treatment Group N0949 On-Study Form</td>
				<td>3163714</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>NSABP PROTOCOL C-08 ADVERSE EVENT FORM</td>
				<td>2292448</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Toxicity</td>
				<td>NSABP C-08</td>
				<td>NSABP C-08</td>
			</tr>

			<tr class="rowColor">
				<td>NSABP PROTOCOL C-09: ADVERSE EVENT FORM</td>
				<td>2319856</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Toxicity</td>
				<td>NSABP-C-09</td>
				<td>NSABP-C-09</td>
			</tr>

			<tr>
				<td>Outcome Measures NCI Standard Template</td>
				<td>2857361</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>caBIG</td>
				<td>CRF</td>
				<td>Response</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>PACCT-1 TAILORx Follow-up Form</td>
				<td>2431963</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>PACCT-1</td>
				<td>PACCT-1</td>
			</tr>

			<tr>
				<td>Pathology Report</td>
				<td>3300776</td>
				<td>1.0</td>
				<td>RETIRED PHASED OUT</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Pathology</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Pathology Report</td>
				<td>3300776</td>
				<td>2.0</td>
				<td>RELEASED</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Pathology</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Pediatric Soft Tissue Sarcoma - On-Study Form Newly
					Diagnosed Patients</td>
				<td>2292713</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Pediatric Soft Tissue Sarcoma - On-Study Form Recurrent
					Treatment</td>
				<td>2292588</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Phase II Breast Cancer - Advanced Disease On-Study Form</td>
				<td>2583382</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Phase II Breast Pathology Form</td>
				<td>2549749</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Pathology</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Phase II Lung Cancer - Advanced Disease Follow-Up Form</td>
				<td>2399268</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Phase II Lung Cancer - Localized Disease Follow-Up Form</td>
				<td>2402852</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Phase II Lung Cancer - NSCLC Advanced On-Study Form</td>
				<td>2398811</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Phase II Lung Cancer - SCLC On-Study Form</td>
				<td>2404433</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Primary Cervical Cancer - On-Study Form</td>
				<td>2019339</td>
				<td>2.31</td>
				<td>RETIRED ARCHIVED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Primary Cervical Cancer - On-Study Form</td>
				<td>2019339</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Primary Endometrial Cancer - On-Study Form</td>
				<td>2019340</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Primary Endometrial Cancer - On-Study Form</td>
				<td>2019340</td>
				<td>2.31</td>
				<td>RETIRED ARCHIVED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Primary Ovarian Cancer - On-Study Form</td>
				<td>2019341</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Prior Surgery</td>
				<td>3328984</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Prior Surgery Supplement</td>
				<td>3279314</td>
				<td>1.0</td>
				<td>RETIRED PHASED OUT</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>PRIOR SURGERY SUPPLEMENT</td>
				<td>2398212</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>caBIG</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>C3D Adopter Template Forms</td>
				<td></td>
			</tr>

			<tr>
				<td>Prior Surgery Supplement</td>
				<td>3279314</td>
				<td>2.0</td>
				<td>RELEASED</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Procedures</td>
				<td>3347807</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>PROCEDURES</td>
				<td>2406656</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>caBIG</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>C3D Adopter Template Forms</td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Procedures (Literal Laboratory)</td>
				<td>3291321</td>
				<td>2.0</td>
				<td>RELEASED</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Lab</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Procedures (Literal Laboratory)</td>
				<td>3291321</td>
				<td>1.0</td>
				<td>RETIRED PHASED OUT</td>
				<td>CCR</td>
				<td>CRF</td>
				<td>Lab</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Prostate Cancer - Pathology Form - Metastatic Specimens</td>
				<td>2279630</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Pathology</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Recurrent Gynecologic Cancer - On Study Form, GOG-0209,
					Form OS-R</td>
				<td>2077062</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td>GOG-0209</td>
				<td>GOG-0209</td>
			</tr>

			<tr class="rowColor">
				<td>Recurrent Gynecologic Cancer - On-study Form</td>
				<td>2019342</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Relapse/Progression [ABTR01B1]</td>
				<td>2167755</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>ABTR01B1</td>
				<td>ABTR01B1</td>
			</tr>

			<tr class="rowColor">
				<td>Resectable Pancreatic Cancer - On-Study Form</td>
				<td>2020205</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>RTOG 0534 F1: Phase III STAD with Pelvic LN or Prostate
					only RT for Rising PSA after Radical Prostatectomy Follow-up Form</td>
				<td>2600005</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>RTOG 0534 FO: Interim Follow-up Form</td>
				<td>2600263</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>RTOG 1115 F0: Phase III RT + Standard ADT vs RT + Enhanced
					ADT + TAK-700 Interim Evaluation/Treatment Summary</td>
				<td>3294865</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Treatment</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>RTOG 1115 F1: Disease Assessment</td>
				<td>3356234</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>RTOG 1115 F1: Phase III RT + Standard ADT vs RT + Enhanced
					ADT + TAK-700 Follow-Up Form</td>
				<td>3289581</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>RTOG-0412 F1: Follow-Up Form</td>
				<td>2293590</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>RTOG-0412</td>
				<td>RTOG-0412</td>
			</tr>

			<tr>
				<td>RTOG-0412 FO: Post Induction Follow-Up Form</td>
				<td>2292884</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>RTOG-0412</td>
				<td>RTOG-0412</td>
			</tr>

			<tr class="rowColor">
				<td>RTOG-0617 F1: Radiation Therapy Oncology Group Phase III
					Lung Pre-Op Chemotherapy vs. Pre-Op Concurrent Chemoradiation for
					NSCLC Follow-up Form</td>
				<td>2556229</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>S0205 Advanced GI Carcinoma Prestudy Form</td>
				<td>2035482</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0205</td>
				<td>S0205</td>
			</tr>

			<tr class="rowColor">
				<td>S0205 Advanced Pancreas Carcinoma Prestudy Form</td>
				<td>2307178</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0205</td>
				<td>S0205</td>
			</tr>

			<tr>
				<td>S0502 Advanced GIST PreStudy Form</td>
				<td>2320300</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0502</td>
				<td>S0502</td>
			</tr>

			<tr class="rowColor">
				<td>S1007 Supplementary Follow-Up Form (FUS1007)</td>
				<td>3139763</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Sarcoma - Follow-Up Form</td>
				<td>2290562</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Solid Tumor Relapse Form</td>
				<td>2626175</td>
				<td>1.0</td>
				<td>RETIRED WITHDRAWN</td>
				<td>NHLBI</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Solid Tumor: Disease Description</td>
				<td>2638103</td>
				<td>1.0</td>
				<td>RETIRED WITHDRAWN</td>
				<td>NHLBI</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>SOUTHWEST ONCOLOGY GROUP Advanced Breast Cancer Prestudy
					Form (S0347)</td>
				<td>2286064</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0347</td>
				<td>S0347</td>
			</tr>

			<tr>
				<td>SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM
					(S0307)</td>
				<td>2277562</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>S0307</td>
				<td>S0307</td>
			</tr>

			<tr class="rowColor">
				<td>SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0347)</td>
				<td>2412719</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0347</td>
				<td>S0347</td>
			</tr>

			<tr>
				<td>SOUTHWEST ONCOLOGY GROUP S0221 SUPPLEMENTARY FOLLOW UP FORM</td>
				<td>2101304</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>S0221</td>
				<td>S0221</td>
			</tr>

			<tr class="rowColor">
				<td>SOUTHWEST ONCOLOGY GROUP S0227 ADVANCED CERVICAL CARCINOMA
					PRESTUDY FORM</td>
				<td>2056878</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0227</td>
				<td>S0227</td>
			</tr>

			<tr>
				<td>SOUTHWEST ONCOLOGY GROUP S0303 Advance GI Carcinoma
					Prestudy Form</td>
				<td>2166748</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0303</td>
				<td>S0303</td>
			</tr>

			<tr class="rowColor">
				<td>SOUTHWEST ONCOLOGY GROUP S0307 SUPPLEMENTARY FOLLOW-UP FORM</td>
				<td>2287249</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>S0307</td>
				<td>S0307</td>
			</tr>

			<tr>
				<td>SOUTHWEST ONCOLOGY GROUP S0500 Prestudy Form</td>
				<td>2436725</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0500</td>
				<td>S0500</td>
			</tr>

			<tr class="rowColor">
				<td>SOUTHWEST ONCOLOGY GROUP S0518 Prestudy Form</td>
				<td>2459443</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td>S0518</td>
				<td>S0518</td>
			</tr>

			<tr>
				<td>Southwest Oncology Group S0600 Prestudy Form</td>
				<td>2484582</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Pre-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Southwest Oncology Group S0819 Lung Carcinoma First Site(s)
					Of Progression Or Relapse Form</td>
				<td>2863883</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Superficial Bladder Cancer - Follow-Up Form</td>
				<td>2019332</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>SURVIVAL</td>
				<td>2407587</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>caBIG</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>C3D Adopter Template Forms</td>
				<td></td>
			</tr>

			<tr>
				<td>Survival</td>
				<td>3280857</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CCR</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Survival</td>
				<td>3280857</td>
				<td>2.0</td>
				<td>DRAFT NEW</td>
				<td>CCR</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Survival</td>
				<td>3348853</td>
				<td>1.0</td>
				<td>DRAFT NEW</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td></td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Unresectable Pancreatic Cancer - On-Study Form</td>
				<td>2020206</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Upper Gastrointestinal Cancers - Follow Up Form</td>
				<td>2020208</td>
				<td>2.31</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>USMCI 8214: Adverse Event Form - Expedited</td>
				<td>2834428</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Transmittal</td>
				<td></td>
				<td></td>
			</tr>

			<tr>
				<td>Waldenstroms Macroglobulinemia - On-Study Form</td>
				<td>2273908</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>TEMPLATE</td>
				<td>On-Study</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Z1031: Extended Follow-up Form</td>
				<td>2316464</td>
				<td>3.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td>ACOSOG-Z1031</td>
				<td>ACOSOG-Z1031</td>
			</tr>

			<tr>
				<td>Z1041: Extended Follow-up Form</td>
				<td>2533635</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

			<tr class="rowColor">
				<td>Z1041: Tumor Measurement Report (TMR)</td>
				<td>2536229</td>
				<td>1.0</td>
				<td>RELEASED</td>
				<td>CTEP</td>
				<td>CRF</td>
				<td>Follow-Up</td>
				<td></td>
				<td></td>
			</tr>

		</tbody>
	</table>
</div>